Search

Your search keyword '"Nagata, Naoki"' showing total 423 results

Search Constraints

Start Over You searched for: Author "Nagata, Naoki" Remove constraint Author: "Nagata, Naoki"
423 results on '"Nagata, Naoki"'

Search Results

1. Multicenter phase II study of capecitabine plus oxaliplatin in older patients with advanced gastric cancer: the Tokyo Cooperative Oncology Group (TCOG) GI-1601 study

2. First pediatric pelvic surgery with the Senhance® robotic surgical system: A case series.

5. A placebo-controlled, double-blind, randomized study of recombinant thrombomodulin (ART-123) to prevent oxaliplatin-induced peripheral neuropathy

6. MO39-1 CapeOX therapy for elderly pts with advanced gastric cancer (phase II study with geriatric assessment, TCOG GI-1601)

7. P57-5 A case report of primary unresectable hilar cholangiocarcinoma eventually causing colonic obstruction due to peritoneal dissemination after chemoradiation

8. Correction to: A placebo‑controlled, double‑blind, randomized study of recombinant thrombomodulin (ART‑123) to prevent oxaliplatin‑induced peripheral neuropathy

12. Multicenter open-label randomized phase II study of second-line panitumumab and irinotecan with or without fluoropyrimidines in patients with KRAS wild-type metastatic colorectal cancer (PACIFIC study)

13. Phase II trial evaluating the efficacy of capeOX in elderly patients with advanced gastric cancer using geriatric assessment (TCOG GI-1601).

14. A Case of Laparoscope-assisted Total Pelvic Exenteration after Multimodal Treatment for Anal Canal Adenocarcinoma with Proximal Intramural Spread

15. Multicenter randomized phase II clinical trial of oxaliplatin reintroduction as a third- or later-line therapy for metastatic colorectal cancer—biweekly versus standard triweekly XELOX (The ORION Study)

17. Multicenter, single‐arm, phase II study of the continuous use of panitumumab in combination with FOLFIRI after FOLFOX for RAS wild‐type metastatic colorectal cancer: Exploratory sequential examination of acquired mutations in circulating cell‐free DNA

26. A Case of Ascending Colon Cancer with Skull Metastasis

29. High-mobility group box 1 is involved in the initial events of early loss of transplanted islets in mice

42. UGT1A1*6, 1A7*3, and 1A9*22 genotypes predict severe neutropenia in FOLFIRI-treated metastatic colorectal cancer in two prospective studies in Japan

44. Correction to: A placebo‑controlled, double‑blind, randomized study of recombinant thrombomodulin (ART‑123) to prevent oxaliplatin‑induced peripheral neuropathy

45. Phase Ib/II Study of Biweekly TAS-102 in Combination with Bevacizumab for Patients with Metastatic Colorectal Cancer Refractory to Standard Therapies (BiTS Study)

46. Final results of multicenter phase Ib/ II study of biweekly trifluridine/tipiracil with bevacizumab combination for patients with mCRC refractory to standard therapies (BiTS study).

Catalog

Books, media, physical & digital resources